Causal relationship of immune cell characteristics in hepatocellular carcinoma: A multi-omics analysis based on Mendelian randomization

肝细胞癌中免疫细胞特征的因果关系:基于孟德尔随机化的多组学分析

阅读:1

Abstract

The tumor immune microenvironment of hepatocellular carcinoma (HCC) is complex, yet the causal relationship between immune cell subpopulations and HCC risk remains incompletely elucidated. This study aims to systematically evaluate the causal association between immune cell subpopulations and HCC using Mendelian randomization (MR) analysis, and to validate the biological mechanisms underlying these associations through multi-omics data. Bidirectional two-sample MR analysis was performed to examine causal relationships between 731 immune cell subpopulations and HCC. Inverse-variance weighting (IVW) served as the primary analysis method, with robustness validation through Bayesian weighted MR (BWMR) and machine learning algorithms. Therefore, for significantly associated immune subpopulations, independent analyses of gene expression, prognosis, and tumor immune microenvironment were conducted using HCC data from the Cancer Genome Atlas (TCGA) LIHC cohort. MR analysis and validation identified 21 immune cell subpopulations with significant causal associations to HCC risk. Among these, 12 were identified as risk factors, and 9 as protective factors. Validation in the TCGA cohort revealed that risk-associated immune subpopulations were predominantly enriched for markers of T cell exhaustion and immunosuppressive microenvironments, whereas protective subpopulations likely represented a distinct regulatory B cell subset whose function was associated with the anti-inflammatory factor interleukin-10. This study genetically confirms that specific immune cell functional subpopulations constitute causal risk factors for HCC. These subpopulations exert their effects by shaping distinct tumor immune microenvironments. These findings provide novel mechanisms for understanding the immunopathogenesis of HCC and identify potential targets for developing novel immune intervention strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。